Medis Therapeutics is a Strategic Business Unit focused on innovative medicines.
It provides the full range of services required for successful product commercialization throughout the CEE region while maintaining the highest ethical and compliance standards.
Medis Therapeutics has a proven track record in developing market access strategies and successfully negotiating with payers. Our tailored medical, marketing and sales approach to different product groups and therapeutic areas enables us to inform and support our stakeholders, resulting in optimal product launch and positioning.
With our world-class commercial expertise, we ensure better treatment outcomes for patients.
Our expertise lies in specialty and orphan pharmaceuticals and we have a solid presence in the following therapeutic areas:
- Neurology
- Pulmonology
- Ophthalmology
- Oncology
- Rare diseases
- Dermatology
- Rheumatology
- Hematology
- Endocrinology
- Gynecology
